Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7498 p464
19 April 2008

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Treatment with statins leads to modest reduction in BP

Use of statins in individuals with no known cardiovascular disease or diabetes results in a modest, but significant, reduction in blood pressure, a new study suggests (Archives of Internal Medicine 2008;168:721).

Researchers compared the effects of statins with those of placebo in 973 individuals who did not have diabetes or cardiovascular disease. For six months between 2000 and 2004 participants were assigned to take 20mg simvastatin, 40mg pravastatin or placebo.

Among individuals assigned to take statins, systolic blood pressure decreased by an average of 2.2mmHg and diastolic blood pressure decreased by an average of 2.4mmHg. The effect of statins on blood pressure was not evident at one month of treatment, was significant at six months of treatment and dissipated two months after treatment ended.

“This study adds to our understanding of the effects of statins, currently the best-selling prescription drugs in the world,” the researchers say.

“The reduction in blood pressure seen with statins may contribute — among other identified factors — to some of the ‘rapid’ cardiovascular benefits of statins, arising too swiftly to be explained by effects of statins on plaque accumulation.”

Back to Top


©The Pharmaceutical Journal